ENDRA Life Sciences Q3 EPS $(0.05), Inline
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
Gainers
UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also reported better-than-expected Q3 sales results.
ENDRA Life Sciences: Q2 Earnings Insights
ENDRA Life Sciences (NASDAQ:NDRA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell
• Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
Preview: ENDRA Life Sciences Earnings
ENDRA Life Sciences (NASDAQ:NDRA) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement.